RNAC Next Earnings Date Notes

— Cartesian Therapeutics (NASDAQ: RNAC) is a clinical-stage biotechnology company focused on developing novel RNA cell therapies for autoimmune diseases and other serious conditions. Utilizing an innovative approach known as RNA Armory®, Cartesian transforms patient-derived immune cells by engineering them with RNA, enabling targeted and programmable treatments with greater safety compared to traditional gene therapies. The company's lead candidate, Descartes-08, is in Phase 2 trials for generalized myasthenia gravis, with other programs advancing in autoimmune diseases and oncology. For investors tracking RNAC, key business metrics include clinical trial progress (especially patient enrollment and top-line data readouts), regulatory milestones, and safety/efficacy data updates. Additionally, monitoring cash runway & R&D spend is vital since these indicate financial sustainability and operational execution. Partnerships, licensing activity, and management commentary on commercial strategy are also relevant, as they impact potential future revenue streams. As you prepare to listen to the next earnings call, focus on pipeline updates, trial timelines, and any shifts in guidance that may impact RNAC's long-term growth prospects or value proposition within the competitive landscape. The next projected earnings date for RNAC is 8/6/2026 7:00 am (stay tuned for a confirmed earnings date once announced).

RNAC Next Earnings Date FAQ

On this page we presented the RNAC Next Earnings Date information for Cartesian Therapeutics along with recent past earnings dates. For Q1 of 2026, RNAC reported earnings of -1.460/share, with the earnings report taking place on 4/30/2026. For Q4 of 2025, RNAC reported earnings of -1.390/share, with the earnings report taking place on 3/9/2026. For Q3 of 2025, RNAC reported earnings of -1.380/share, with the earnings report taking place on 11/6/2025. For Q2 of 2025, RNAC reported earnings of 0.500/share, with the earnings report taking place on 8/7/2025. For Q1 of 2025, RNAC reported earnings of -0.680/share, with the earnings report taking place on 5/8/2025. Based on these past earnings dates, the projected next earnings date for RNAC is 8/6/2026 7:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Cartesian Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Cartesian Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Cartesian Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next RNAC earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up RNAC's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the RNAC next earnings date.